MARSHALL BARRY JAMES has a total of 22 patent applications. Its first patent ever was published in 1986. It filed its patents most often in EPO (European Patent Office), Germany and Ireland. Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are T3D THERAPEUTICS INC, CLOVIS ONCOLOGY INC and BLACKMAN RONALD K.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Germany | 3 | |
#3 | Ireland | 3 | |
#4 | Australia | 2 | |
#5 | South Africa | 2 | |
#6 | Brazil | 1 | |
#7 | Denmark | 1 | |
#8 | Hong Kong | 1 | |
#9 | Japan | 1 | |
#10 | Mexico | 1 | |
#11 | Norway | 1 | |
#12 | New Zealand | 1 | |
#13 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Marshall Barry James | 18 |
#2 | Marshall Barry James Dr | 1 |
Publication | Filing date | Title |
---|---|---|
EP0462631A1 | Methods and compositions for the treatment of gastrointestinal disorders | |
EP0206626A2 | Use of Bismuth for the manufacture of a medicament for the treatment of gastrointestinal disorders induced by Campylobacter polyridis | |
ZA8603605B | Compositions and methods for the detection of urease for the diagnosis of campylobacter pyloridis infection | |
AU5739886A | Compositions and methods for the detection of urease for the diagnosis of gastrointestinal disorder |